Synthetic Biology Market North America
Active Pharmaceutical Ingredients (API) market size was valued at USD 179.77 billion in 2018 and is projected to reach to USD billion by 2026 at a CAGR of %. This is a comprehensive global report focused on the current and future prospects of the active pharmaceutical ingredients market. This report is a consolidation of primary and secondary research, which provides market size, share, dynamics, and forecast for various segments and sub-segments considering the macro and microenvironmental factors. An in-depth analysis of past trends, future trends, demographics, and technological advancements for the active pharmaceutical ingredients market has been done in order to calculate the growth rates for each segment and sub-segments.
Furthermore, augmented demand for rapid-acting & efficient drugs and the emergence of innovative drug manufacturing facilities are expected to assist in market growth during the forecast period.
Loss of drug exclusivity is impeding the revenue growth!
The branded/innovative drugs segment spearheaded the market.
A surge in prescription rates and drug prices coupled with higher spending on R&D activities are expected to contribute to the dominance of the branded/innovative drugs segment.
• Competitive landscape of the key players operating in the active pharmaceutical ingredients market including competitive developments, investments, and strategic expansion
Years that have been considered for the study are as follows:• Base Year – 2018
• Estimated Year – 2019
• Forecast Period – 2019 to 2026
Some of the key players of the active pharmaceutical ingredients market include:
• AbbVie Inc.
• Bristol-Myers Squibb Company
• Boehringer Ingelheim GmbH
• Cipla Inc.
• Merck & Co., Inc.
• Eli Lilly and Company
• Mylan N.V.
• Teva Active Pharmaceuticals Industries Ltd.
• Aurobindo Pharma
• Sun Pharmaceutical Industries, Ltd.
• Dr. Reddy’s Laboratories Ltd.
• Albemarle Corporation
Key Target Audience:
Author Signature :
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors. "
About Maximize Market Research: Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healt..